NOLAND HOSPITAL TUSCALOOSA II — History
CCN 012012 | 3-year financial timeline | COVID resilience: 27/100
🛡️ Public data only — no PHI permitted on this instance.
$6M
Latest Revenue (FY2022)
-12.6%
Revenue CAGR (3yr)
11.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $8M | $6M | $6M | -6.9% | -12.6% |
| Operating Expenses | $6M | $5M | $5M | -4.4% | -10.6% |
| Operating Margin | 15.1% | 13.7% | 11.3% | -17.6% | -13.8% |
| Net Income | $1M | $1M | $1M | -23.3% | -24.6% |
| Licensed Beds | 32 | 32 | 32 | +0.0% | +0.0% |
| Total Patient Days | 5,204 | 4,117 | 3,686 | -10.5% | -15.8% |
| Medicare Day % | 64% | 59% | 49% | -17.3% | -12.8% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 27/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -23.6% ($8M → $6M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-12.6%
This Hospital
+7.6%
State Avg
Latest Margin
11.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $5M | 9.3% |
| FY2024 (proj) | $4M | 7.4% |
| FY2025 (proj) | $3M | 5.4% |